In multiple myeloma where GDF-15 is produced by bone marrow stromal cells rather than by the tumor, increased GDF-15 serum levels were associated with a tumor-promoting microenvironment, as demonstrated by enhanced clonogenic growth of multiple myeloma cells and reduced progression-free survival (96). Here, GDF15 is linked to AL amyloidosis.